Skip to main content
. 2020 Jan 10;16(1):e1008268. doi: 10.1371/journal.ppat.1008268

Fig 6. KDM2B binds to the KSHV genome in the latently infected BCBL1 cells.

Fig 6

(A) KDM2B ChIP assay was performed in latent BCBL1 cells. The KDM2B binding was tested at the indicated regions of RTA promoter and in the RTA gene body +0.8 kb downstream of the transcription start site. IgG ChIP was performed to determine the specificity of KDM2B ChIPs. (B) Testing the binding of KDM2B on the promoter (pr) and the gene body (gb) of E (K2) and L (ORF25) genes in latent BCBL1 cells. Cellular intergenic region Neg was used as a negative control.